Inhibikase Therapeutics Inc (NAS:IKT)
$ 1.81 -0.02 (-1.09%) Market Cap: 11.72 Mil Enterprise Value: 2.18 Mil PE Ratio: 0 PB Ratio: 1.73 GF Score: 41/100